Rhopressa netarsudil fda approval date december 18 2017?

When did Rhopressa (netarsudil) get FDA approval?

Rhopressa (netarsudil ophthalmic solution) received FDA approval on December 18, 2017.

What is Rhopressa used for?

Rhopressa is used to lower intraocular pressure in people with open-angle glaucoma or ocular hypertension.

Where can I verify the approval date?

You can cross-check FDA approval and related patent/exclusivity information at DrugPatentWatch.com: https://www.drugpatentwatch.com/